INFLA MOVNew

                                                                                                                                                                                                                                
Contents                
              
  • Vial: KPV (α-MSH fragment tripeptide) 10mg/vial × 5
  •           
  • Ampoule: 2ml Bacteriostatic Water
  •         
      
Description        INFLA MOV is an advanced peptide formulation containing KPV, a bioactive tripeptide derived from alpha-Melanocyte Stimulating Hormone (α-MSH), known for its strong anti-inflammatory and immunomodulatory effects.

        KPV works by regulating inflammatory pathways through inhibition of pro-inflammatory cytokines, helping to control both systemic and localized inflammation. Unlike many traditional therapies, it supports immune balance without causing significant immunosuppression.

        INFLA MOV is widely used in protocols targeting gut health, skin repair, and tissue healing. It supports recovery from inflammatory conditions, promotes cellular repair, and contributes to improved overall physiological resilience.      
AdministrationSubcutaneous (SC) injection.
Storage        
              
  • Before reconstitution: Store at room temperature, away from heat and direct sunlight.
  •           
  • After reconstitution: Refrigerate between 2–8°C.
  •         
      
Dosage        Typical: 200–500 mcg per day. Dosage may be adjusted based on condition and response. Administer under medical supervision.      
Indication        INFLA MOV may be used in:        
              
  • Gut inflammation (e.g., IBS, inflammatory bowel conditions)
  •           
  • Skin disorders and irritation
  •           
  • Joint inflammation
  •           
  • Systemic inflammatory conditions
  •           
  • Tissue repair and recovery support
  •         
      
Contraindications        Do not use INFLA MOV if:        
              
  • Hypersensitivity to KPV or peptide components
  •           
  • Pregnancy and lactation
  •           
  • Severe uncontrolled medical conditions without supervision
  •         
      
Special Precautions        
              
  • Use under medical supervision.
  •           
  • Monitor response in patients with chronic inflammatory or autoimmune conditions.
  •           
  • Long-term safety data is limited.
  •         
      
Adverse Drug Reactions        
              
  • Generally well tolerated
  •           
  • Common: Injection site irritation, redness
  •           
  • Others: Transient fatigue
  •           
  • Rare: Allergic reactions
  •         
      
Drug Interactions        Limited data available. Use cautiously with:        
              
  • Immunomodulatory medications
  •           
  • Anti-inflammatory drugs
  •         
      
Disclaimer        Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice.